CN101129718B - Traditional Chinese medicine preparation for treating leuoderma - Google Patents
Traditional Chinese medicine preparation for treating leuoderma Download PDFInfo
- Publication number
- CN101129718B CN101129718B CN200710056063A CN200710056063A CN101129718B CN 101129718 B CN101129718 B CN 101129718B CN 200710056063 A CN200710056063 A CN 200710056063A CN 200710056063 A CN200710056063 A CN 200710056063A CN 101129718 B CN101129718 B CN 101129718B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine preparation
- medicines
- flos carthami
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a Chinese medicinal preparation for treating leukoderma, which is prepared from alkanna tinctoria, dalbergia wood, rhizome of Chinese paris, head stephania root, swallowwort root, atractylodes rhizome, Os Sepiae, safflower, peach kernels, tuber of multiflower knotweed, gentian root and Tribulus terrestris.
Description
Technical field
The present invention discloses the leukodermic Chinese medicine preparation of a kind of treatment, is used for the treatment of the vitiligo disease, belongs to Chinese medicine pharmaceutical technology field.
Background technology
Vitiligo is also referred to as leucoderma, erosion or vitiligo in vain, is a kind of pigmented dermatosis of common pilosity, and this disease is with local or general property depigmentation, and the formation white macula is a feature.Generation is all arranged all over the world, and India's sickness rate is the highest, and China has 1,200 ten thousand people morbidity approximately, and primary disease can involve all races, men and women's no marked difference of falling ill.In recent years sickness rate rises year by year, causes people's common concern.Tcm theory thinks that leukodermic morbidity is the synergistic result of body internal and external factor.In because the liver spleen suffer from a deficiency of the kidney, how by deficiency of liver-blood, insufficiency of kidney-YANG, deficiency of kidney-QI, cause and make the body yin and yang imbalance, qi-blood disharmony.On this basis, damp and hot ailment said due to cold or exposure is taken advantage of a weak point, and the visitor goes into skin, impatency meridians blood vessels, and skin must not be warm, and skin and hair loses to support and causes the pigment cell to take off mistake, and local or whole body skin forms white macula and falls ill.Its Therapeutic Principle serves as main the treatment with nourishing blood to expel wind, blood circulation promoting and blood stasis dispelling, existing medicine: lose Chinese patent medicines such as ball, vitiligo capsule in vain, but in the clinical treatment process, list is cut with the uncertain therapeutic efficacy of a certain medicine, can only reach recent clinical effectiveness, recurrent is stronger.
The doctor trained in Western medicine theory emphasizes that then vitiligo is to disappear owing to skin pigment that the skin metabolism obstacle causes, does not still have effective Therapeutic Method at present.
Summary of the invention
The invention provides the leukodermic Chinese medicine preparation of a kind of treatment, determined curative effect, clinical symptoms is improved obviously, cures the back and is difficult for recurrence.
To leukodermic pathogenesis and Therapeutic Principle, selected following pure Chinese crude drug is made Chinese medicine preparation: (by weight) through the scientific composition compatibility according to China's Chinese medicine in the present invention
Radix Arnebiae (Radix Lithospermi) 35~55, Lignum Dalbergiae Odoriferae 35~55, Rhizoma Paridis 35~55, Radix Stephaniae Cepharanthae 35~55, Radix Cynanchi Atrati 35~55, Rhizoma Atractylodis 15~20, Endoconcha Sepiae 25~35, Flos Carthami 35~50, Semen Persicae 40~55, Radix Polygoni Multiflori 40~50, Radix Gentianae 18~25, Fructus Tribuli 650~750
Optimum ratio of the present invention is:
Radix Arnebiae (Radix Lithospermi) 50, Lignum Dalbergiae Odoriferae 50, Rhizoma Paridis 50, Radix Stephaniae Cepharanthae 50, Radix Cynanchi Atrati 50, Rhizoma Atractylodis 20, Endoconcha Sepiae 35, Flos Carthami 50, Semen Persicae 50, Radix Polygoni Multiflori 45, Radix Gentianae 20, Fructus Tribuli 750.
Processing procedure of the present invention is as follows:
Adopt traditional pill preparation method, above-mentioned each medicine taken by weighing in proportion, clean and to be ground into 60~90 order fine powders after removing impurity, slowly add Mel, stir and all make pill, pharmaceutical preparation of the present invention.
Usage and dosage: every day twice, each ball (6~10g/ ball);
It is better to be used " BAIDIANJING " medicine for external use result of use.
Be the blood circulation promoting and blood stasis dispelling tissue regeneration promoting with Flos Carthami, Semen Persicae, Radix Polygoni Multiflori among the present invention, the blood that row skin stagnates, the expansion local vascular improves histotrophic nutrition, invigorating the liver and kidney, benefiting essence-blood; Radix Stephaniae Cepharanthae, Radix Cynanchi Atrati can loose wind except that alunite; It is damp and hot that Radix Arnebiae (Radix Lithospermi), Lignum Dalbergiae Odoriferae, Rhizoma Paridis are apt to remove skin, sterilization detoxifcation, promoting tissue regeneration by removing blood stasis, raising immunity; Rhizoma Atractylodis, Endoconcha Sepiae, Radix Gentianae, the Fructus Tribuli phoenix eliminating stagnation of dispelling, suppressing the hyperactive liver is opened all, controls the skin pruritus due to wind pathogen.All medicines share make microcirculation vigorous, regulate body's immunity and homeostasis, nourishing the liver and kidney, benefiting QI and nourishing blood, expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, collateral dredging speckle removing are with Zhi Qiben.
We's gas cloudy two is mended, and negative and positive are taken into account, and not wet not dry, the medicine is mild.
The curative effect of following case proof medicine of the present invention:
Observe 20 routine patients altogether, cure 8 people (40%), pigment recovers fully; Produce effects 9 people (45%), pigment recovers substantially; Effective 2 people (10%), pigment partly recovers; Invalid 1 people (5%), pigment does not have change.
Case 1
Zhao, man, 50 years old, patient found that before 4 years the bilateral waist respectively has the white macula district of size as 1 Semen Glycines, observes when going to a doctor and finds that two waists, abdominal part have formed 3 2~3.5cm after 1 year
2White macula, forehead, two cheek to two glabellas have 8 2~25cm of symmetrical distribution
2White macula district, the left and right sides, the patient once went to a doctor in how tame hospital, and was in taking, the Western medicine several months, all invalid.Use medicine of the present invention, through treatment in 5 months, two cheeks, two eyebrows place white macula be the normal colour of skin of full recovery, forehead, two cheek white maculas district has a large amount of chromogenesis, and 1~20mm contracts in the edge, the normal colour of skin of 120 days back lumbar part white maculas full recovery, not recurrence so far after the consolidation.
Case 2
The Wang, the woman, 20 years old, the workman, corners of the mouth extremity are dispersed in the type vitiligo, have a delicate constitution, and immunologic hypofunction was fallen ill 1 year, and the white macula development is rapid, the comprehensive about 9cm of area
2, it is invalid to seek medical advice in many ways.Take medicine of the present invention, white macula no longer spreads, and is dispersed in the small size white macula and disappears, and body constitution strengthens, and recovery from illness in 5 months is almost recovered after after treatment, does not now see recurrence so far.
Case 3
High certain, the man, 31 years old, the patient falls ill, and it was 6 years, branch is at hands, face, cervical region, the comprehensive about 3cm of area
2, belong to the type that distributes.Take medicine of the present invention, put on the skin repeatedly and smear site of disease, every day 3~4 times, each 3~5 minutes, treated 3 months, pars affecta skin begins the pulverize redness, and the state of an illness gets control fully, be transformed into the pigmentation point gradually, continue medication 3 months, pigmentation point enlarges gradually until recovery from illness.Followed up a case by regular visits to 6 months, and do not see rebound phenomenon.
Good effect of the present invention is: the pure Chinese medicinal preparation prescription, have the completeness of treatment, and treated about 15~20 days, skin color is deepened or the pigment island occurs, white macula fades away after three course of therapy again, and skin recovers normal color, does not recur after healing.Clinical effectiveness is remarkable, non-relapse after healing.
The specific embodiment
For the ease of understanding the present invention, especially exemplified by following examples.Its effect is understood that it is to explaination of the present invention but not to any type of restriction of the present invention.
Embodiment 1
Take by weighing Radix Arnebiae (Radix Lithospermi) 50kg, Lignum Dalbergiae Odoriferae 50kg, Rhizoma Paridis 50kg, Radix Stephaniae Cepharanthae 50kg, Radix Cynanchi Atrati 50kg, Rhizoma Atractylodis 20kg, Endoconcha Sepiae 35kg, Flos Carthami 50kg, Semen Persicae 50kg, Radix Polygoni Multiflori 45kg, Radix Gentianae 20kg, Fructus Tribuli 750kg, clean and to be ground into 80 order fine powders after removing impurity, add peak honey, make pill (about 5 grams of every bolus quantities), other should meet People's Republic of China's version pharmacopeia in 2000 pill item.
Embodiment 2
Take by weighing Radix Arnebiae (Radix Lithospermi) 35kg, Lignum Dalbergiae Odoriferae 40kg, Rhizoma Paridis 35kg, Radix Stephaniae Cepharanthae 55kg, Radix Cynanchi Atrati 45kg, Rhizoma Atractylodis 15kg, Endoconcha Sepiae 25kg, Flos Carthami 40kg, Semen Persicae 45kg, Radix Polygoni Multiflori 40kg, Radix Gentianae 18kg, Fructus Tribuli 650kg, clean and to be ground into 100 order fine powders after removing impurity, add Mel furnishing pill, other should meet People's Republic of China's version pharmacopeia in 2000 pill item.
Embodiment 3
With Radix Arnebiae (Radix Lithospermi) 55kg, Lignum Dalbergiae Odoriferae 35kg, Rhizoma Paridis 55kg, Radix Stephaniae Cepharanthae 35kg, Radix Cynanchi Atrati 35kg, Rhizoma Atractylodis 20kg, Endoconcha Sepiae 35kg, Flos Carthami 35kg, Semen Persicae 40kg, Radix Polygoni Multiflori 50kg, Radix Gentianae 25kg, Fructus Tribuli 750kg, clean and to be ground into 80 order fine powders after removing impurity, canned one-tenth capsule, other should meet People's Republic of China's version pharmacopeia in 2000 capsule item.
Claims (3)
1. treat leukodermic Chinese medicine preparation for one kind, it is characterized in that making by following parts of medicines by weight:
Radix Arnebiae (Radix Lithospermi) 35~55, Lignum Dalbergiae Odoriferae 35~55, Rhizoma Paridis 35~55, Radix Stephaniae Cepharanthae 35~55, Radix Cynanchi Atrati 35~55, Rhizoma Atractylodis 15~20, Endoconcha Sepiae 25~35, Flos Carthami 35~50, Semen Persicae 40~55, Radix Polygoni Multiflori 40~50, Radix Gentianae 18~25, Fructus Tribuli 650~750.
2. Chinese medicine preparation according to claim 1 is characterized in that being made by following parts of medicines by weight:
Radix Arnebiae (Radix Lithospermi) 50, Lignum Dalbergiae Odoriferae 50, Rhizoma Paridis 50, Radix Stephaniae Cepharanthae 50, Radix Cynanchi Atrati 50, Rhizoma Atractylodis 20, Endoconcha Sepiae 35, Flos Carthami 50, Semen Persicae 50, Radix Polygoni Multiflori, Radix Gentianae 20, Fructus Tribuli 750.
3. the production method of Chinese medicine preparation according to claim 1 and 2, it is characterized in that: take by weighing claim 1 or 2 described medicines, mixed grinding becomes 60~100 order powder, canned capsule, or add the peak processed with honey and become pill.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710056063A CN101129718B (en) | 2007-09-12 | 2007-09-12 | Traditional Chinese medicine preparation for treating leuoderma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710056063A CN101129718B (en) | 2007-09-12 | 2007-09-12 | Traditional Chinese medicine preparation for treating leuoderma |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101129718A CN101129718A (en) | 2008-02-27 |
CN101129718B true CN101129718B (en) | 2010-05-19 |
Family
ID=39127230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710056063A Expired - Fee Related CN101129718B (en) | 2007-09-12 | 2007-09-12 | Traditional Chinese medicine preparation for treating leuoderma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101129718B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697905A (en) * | 2012-05-27 | 2012-10-03 | 李承平 | Medicinal combination capsules for dispelling wind, relieving itching, smoothing liver and dispelling melancholy |
CN105288072A (en) * | 2015-12-01 | 2016-02-03 | 陈焕斌 | Traditional Chinese medicine for treating leucoderma |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1217201A (en) * | 1997-11-14 | 1999-05-26 | 黄国泉 | Oral medicine for treating leucoderma and preparation method therefor |
CN1394617A (en) * | 2001-07-09 | 2003-02-05 | 冯小妹 | Medicament for treating leucoderma |
-
2007
- 2007-09-12 CN CN200710056063A patent/CN101129718B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1217201A (en) * | 1997-11-14 | 1999-05-26 | 黄国泉 | Oral medicine for treating leucoderma and preparation method therefor |
CN1394617A (en) * | 2001-07-09 | 2003-02-05 | 冯小妹 | Medicament for treating leucoderma |
Also Published As
Publication number | Publication date |
---|---|
CN101129718A (en) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN100367985C (en) | Chinese prepared medicine for treating bone pain | |
CN102908603B (en) | Chinese medicament for treating hyperplasia of mammary glands | |
CN104547790A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method thereof | |
CN105477595A (en) | Traditional Chinese medicinal preparation for treating chilblain | |
CN102631512B (en) | Traditional Chinese medicine composition for curing chronic colitis | |
CN102198243B (en) | Oviduct dredging medicament for removing blood stasis and warming meridians | |
CN102423444B (en) | Traditional Chinese medicine preparation for treating rheumatism and internal lesion caused by overexertion and preparation method thereof | |
CN102872369A (en) | Traditional Chinese medicine composition for varicella treatment | |
CN102872301A (en) | Anti-rheumatism medicinal liquor and using method thereof | |
CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
CN101708292B (en) | Chinese medicament for treating rheumatic and rheumatoid diseases | |
CN104162088A (en) | Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof | |
CN104055922A (en) | Traditional Chinese medicinal preparation for treating pressure sores and preparation method thereof | |
CN102205067B (en) | Traditional Chinese medicine composition for treating chronic urticaria | |
CN102579607B (en) | Chinese medicine composition for treating acne | |
CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN105412626A (en) | Medicine preparation for treating cervical spine bone hyperplasia and application of medicine preparation | |
CN104758412A (en) | Traditional Chinese medicine composition for treating degenerative gonarthrosis as well as clinic preparation and preparation method of traditional Chinese medicine composition | |
CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
CN102764325B (en) | Chinese medicinal composition for dispelling rheumatism and relieving pain | |
CN102284035A (en) | Chinese composition for treating rhinitis | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN102319348B (en) | Medicament for treating chronic pharyngitis | |
CN106075268A (en) | A kind of Chinese medicine composition treating scabies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 Termination date: 20100912 |